Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$178,976,468
+$5,450,957 QoQ
Shares Held
704,715
-0.7% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#216
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST MANHATTAN CO. LLC. holds $503,568,677 across 13 Drug Manufacturers - General names. JNJ ranks #1 (35.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
704,715 | $178,976,468 | |
| 2 | ABBV |
AbbVie Inc.
|
594,732 | $149,658,360 | |
| 3 | LLY |
ELI LILLY & Co
|
72,685 | $87,180,576 | |
| 4 | AMGN |
Amgen Inc
|
87,079 | $31,533,047 | |
| 5 | MRK |
Merck & Co., Inc.
|
158,760 | $20,400,660 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
70,366 | $8,890,040 | |
| 7 | NVS |
Novartis AG
|
50,123 | $7,855,276 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
118,863 | $6,848,886 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $178,976,468 | 704,715 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $173,525,511 | 709,890 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $142,065,587 | 686,473 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $127,360,733 | 686,877 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $110,098,228 | 720,774 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $130,813,099 | 788,791 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $124,089,455 | 858,038 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $146,969,458 | 906,883 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $157,406,168 | 995,045 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $165,988,600 | 1,059,006 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $173,178,892 | 1,111,903 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $203,351,085 | 1,228,559 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $214,745,370 | 1,385,454 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $265,135,751 | 1,500,910 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $244,191,834 | 1,494,808 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $274,228,986 | 1,544,865 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $284,985,308 | 1,607,997 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $320,077,444 | 1,871,032 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $300,283,894 | 1,859,343 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $311,909,325 | 1,893,343 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $312,996,686 | 1,904,452 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $303,622,060 | 1,929,229 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $292,960,555 | 1,967,763 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $298,254,994 | 2,120,849 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $294,616,065 | 2,246,748 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||